Type 1 diabetes treatment options: insulin therapy, pumps, and beyond
Whether you’re newly diagnosed with type 1 diabetes or rethinking your current routine, it can feel overwhelming at times to manage. The good news is that treatment options have expanded significantly over time. This guide walks you through the different type 1 diabetes treatment options, so you can better understand your choices and have a more informed conversation with your healthcare team.
Understanding how type 1 diabetes is treated
Type 1 diabetes is an autoimmune condition in which the body no longer produces insulin. Insulin is crucial for transporting sugar (glucose) from food out of the bloodstream and into the cells, where it can be used for energy.1 Since insulin is essential for regulating blood glucose, people with type 1 diabetes need to take insulin to treat the condition.
Why insulin is essential for type 1 diabetes
Insulin allows glucose from food to enter the body’s cells for energy. Without it, glucose builds up in the bloodstream, leading to high blood sugar levels. Replacing insulin helps keep blood glucose within a target range and reduces the risk of both short- and long-term complications.
The goal of type 1 diabetes treatment: staying in range
Modern diabetes management is increasingly focused on time in range (TIR), which is the amount of time your glucose levels stay within a target range. The goal of treatment is to support more time in range while reducing both highs and lows, using tools and approaches that fit your daily life.
Type 1 diabetes treatment options
There are several ways to manage type 1 diabetes, all centered around delivering insulin and monitoring glucose levels. These approaches differ in how insulin is delivered, how much automation is involved, and how they fit into daily life.
Multiple daily injections
Multiple daily injections (MDI) are a common way to manage type 1 diabetes using insulin delivered by syringe or pen. This approach typically combines long-acting (basal) insulin to support your body between meals and overnight, with rapid-acting (bolus) insulin taken at mealtimes or to correct high blood sugar.
MDI is often the starting point after diagnosis and can be an effective long-term option. While it offers flexibility without requiring a device, it does rely on manual dose calculations and multiple injections throughout the day.
Insulin pump therapy
Insulin pumps deliver insulin continuously through a wearable device, helping replace the need for multiple daily injections. Instead of separate basal injections, pumps provide small, steady doses of insulin throughout the day, with additional doses given as needed for meals or corrections.
There are two main types of insulin pumps:
- Tubed pumps, which connect the device to the body through thin tubing
- Tubeless pumps, which are worn directly on the body without external tubing
Both approaches are designed to support more precise insulin delivery. The differences typically relate to how the device is worn and how it fits into day-to-day activities.
Continuous glucose monitoring (CGM)
Continuous glucose monitoring provides real-time insights into glucose levels throughout the day and night. A sensor is worn on the body that tracks glucose trends and sends updates to a receiver or smartphone.
CGM can be used alongside any insulin delivery method, including MDI or pump therapy. It helps inform day-to-day decisions by showing how glucose levels respond to food, activity, and insulin, and can provide alerts when levels are trending high or low.
Today, CGM is widely considered a foundational part of managing type 1 diabetes.
Automated insulin delivery (AID) systems
Automated insulin delivery (AID) systems bring together an insulin pump and a CGM to adjust insulin delivery in real time. Using glucose data from the CGM, these systems automatically increase, decrease, or pause insulin delivery to help keep glucose levels within a target range.
Different AID systems are available, each with their own features and compatibility requirements. While AID systems still require user input, they can reduce the number of decisions needed throughout the day.
Combining tools: how these options work together
Type 1 diabetes management is often built from a combination of tools rather than a single approach. Insulin delivery (through injections or a pump) works alongside glucose monitoring, and in some cases, these technologies are integrated.
Each combination offers a different balance of control, flexibility, and support. The best fit depends on individual preferences, daily routines, and comfort with different types of technology.
Advances in type 1 diabetes treatment
Research in T1D continues to evolve, with efforts focused on delaying, modifying, or potentially preventing disease progression.
What the future of type 1 diabetes treatment may look like
Ongoing research includes:
- Beta cell replacement therapies
- Immunotherapies
- Improvements in AID algorithms and device integration
These approaches are still developing and do not replace current insulin-based treatment today.2
Choosing the right type 1 diabetes treatment for you
There is no single “best” treatment approach for type 1 diabetes. The right option depends on your individual needs, preferences, and circumstances.
Factors to consider include:
- Lifestyle and daily routine
- Age and activity level
- Comfort with technology
- Experience with injections
- Insurance coverage and cost
All treatment decisions should be made in collaboration with your diabetes care team.
Questions to ask your diabetes care team
Consider asking your healthcare provider the following questions when discussing what treatment looks like for you:
- What treatment options are available to me right now?
- How might each option fit into my daily routine?
- What are the benefits and limitations of each approach?
- How could a pump or AID system change my management?
- What training or support would I need?
- How does insurance coverage vary across options?
Learn more about Omnipod® 5
Omnipod 5 Automated Insulin Delivery System is an example of an automated insulin delivery system that connects a wearable, waterproof,* and tubeless insulin pump with a compatible continuous glucose monitor.
The Omnipod 5 algorithm is built right into the Pod. The system adjusts insulin delivery based on glucose readings and trends, while still allowing users to bolus for meals.
Related Articles
Other topics
References and Disclaimers
1.Mayo Clinic. Type 1 Diabetes - Symptoms and Causes. Mayo Clinic. Published March 27, 2024. https://www.mayoclinic.org/diseases-conditions/type-1-diabetes/symptoms-causes/syc-20353011
2 .Zhao M, Yao Z. Emerging therapies for type 1 diabetes: Immunotherapy and gene editing advances. Journal of International Medical Research. 2026;54(4). doi:https://doi.org/10.1177/03000605261440833
* The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Controller is not waterproof.
The Omnipod® 5 Automated Insulin Delivery System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older and type 2 diabetes mellitus in persons 18 years of age and older. The Omnipod 5 System is intended for single patient, home use and requires a prescription. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, Admelog®, and Kirsty®.
Refer to the Omnipod 5 Automated Insulin Delivery System User Guide and www.omnipod.com/safety for complete safety information including indications, contraindications, warnings, cautions, and instructions. Warning: DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia. WARNING: SmartAdjust technology should NOT be used by anyone under the age of 2 years old. SmartAdjust technology should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population.
Available products subject to current insurance coverage and product indication for use. Insulet can only support onboarding for those customers within the product indication.